Structures by: Slepukhin P.
Total: 7
Dimethyl[(<i>E</i>)-2-(1-methyl-5-nitro-1<i>H</i>-imidazol-4-yl)ethenyl]amine
C8H12N4O2
IUCrData (2016) 1, 1 x152488
a=10.5015(12)Å b=23.561(3)Å c=7.7533(6)Å
α=90.00° β=96.604(8)° γ=90.00°
(<i>E</i>)-<i>N</i>-[Cyclopentyl(morpholin-4-yl)methylidene]-4-fluorobenzenesulfonamide
C16H21FN2O3S
IUCrData (2016) 1, 1 x160013
a=11.5613(7)Å b=16.4245(13)Å c=8.8730(6)Å
α=90.00° β=107.768(6)° γ=90.00°
Bis{(<i>Z</i>)-(benzylamino)[(5<i>Z</i>)-2-(benzylimino-κ<i>N</i>)-5-(2-methoxy-2-oxoethylidene)-4-oxothiolan-3-ylidene]methanethiolato-κ<i>S</i>}copper(II)
C44H38CuN4O6S4
Acta Crystallographica Section E (2015) 71, 4 m93-m94
a=10.7595(6)Å b=11.6318(5)Å c=18.8162(8)Å
α=104.846(4)° β=91.038(4)° γ=109.119(4)°
Ethyl 3-(4-chlorophenyl)-5-[(<i>E</i>)-2-(dimethylamino)ethenyl]-1,2-oxazole-4-carboxylate
C16H17ClN2O3
Acta Crystallographica Section E (2015) 71, 12 o1028
a=11.5494(13)Å b=12.474(2)Å c=13.0430(13)Å
α=102.369(11)° β=105.501(9)° γ=109.001(13)°
(2<i>Z</i>)-2-{(5<i>Z</i>)-5-[3-Fluoro-2-(4-phenylpiperidin-1-yl)benzylidene]-4-oxo-3-(<i>p</i>-tolyl)-1,3-thiazolidin-2-ylidene}-<i>N</i>-(<i>p</i>-tolyl)ethanethioamide dimethyl sulfoxide monosolvate
C37H34FN3OS2,C2H6OS
Acta Crystallographica Section E (2015) 71, 10 o745-o746
a=9.8539(5)Å b=9.8671(5)Å c=18.1633(8)Å
α=90.00° β=100.578(5)° γ=90.00°
(<i>Z</i>)-<i>N</i>-(4-Methoxyphenyl)-2-(4-oxothiazolidin-2-ylidene)acetamide
C12H12N2O3S
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 12 1850-1854
a=11.628(11)Å b=9.057(6)Å c=11.525(12)Å
α=90.00° β=101.13(8)° γ=90.00°
(<i>Z</i>)-2-[2-(Morpholin-4-yl)-2-oxoethylidene]thiazolidin-4-one
C9H12N2O3S
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 12 1850-1854
a=9.9740(4)Å b=11.2175(4)Å c=9.3155(4)Å
α=90.00° β=100.389(4)° γ=90.00°